The FDA and Abbott Diabetes Care have notified healthcare professionals and patients of a recall of 359 lots of glucose test strips marketed under the brand names: Precision Xceed Pro, Precision Xtra, Medisense Optium, Optium, OptiumEZ and ReliOn Ultima. The recall is related to a defect in the strip that inhibits sufficient absorption of blood. Strips exposed to warm weather or prolonged storage may be more likely to provide a false result. The affected test strips may give falsely low blood glucose results, which can lead patients to try to raise their blood glucose when it is unnecessary, or to fail to treat elevated blood glucose due to a falsely low reading.
Patients and healthcare providers can check if their glucose test strips are affected by the recall at precisionoptiuminfo.com/EN/lookup.php.
For more information visit www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm237910.htm.